Depression, Depressionen

References

American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed rev. Washington, DC: American Psychiatric Association.

American Psychiatric Association Committee on ECT (in press): The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging, 2nd ed. Washington, DC: American Psychiatric Press.

Ballenger JC, Post RM (1978): Therapeutic effects of carbamazepine in affective illness: A preliminary report. Commun Psvchopharmacol 2:159‐-175.

Rudd GD (1999): A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-‐88.

Coding Symbols for Thesaurus of Adverse Reaction Terms, 5th ed (1995): Rockville, MD: Department of Health and Human Services, Center for Drug Evaluation and Research, Office of Epidemiology Biostatistics.

Crismon ML, Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, et al (1999): The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatrv 60:142‐156.

Depression Guideline Panel (1993a): Depression in Primary Care: Volume 1. Detection and Diagnosis (Clinical Guideline No. 5, AHCPR Publication No. 93-0550). Rockville, MD: US. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.

Depression Guideline Panel (1993b): Depression in Primary Care: Volume 2. Treatment of Major Depression (Clinical Guideline No. 5, AHCPR Publication No. 93-0551). Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research.

Devanand DP, Sackeim HA, Prudic J (1991): Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am 14:905‐-923.

Doogan DP, Caillard V (1992): Sertraline in the prevention of depression. Br J Psychiatry 160:217-‐222.

Fatemi SH, Rapport DJ, Calabrese JR, Thuras P (1997): Lam otrigine in rapid-cycling bipolar disorder. J Clin Psychiatry

58:522‐527.

Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, et al (1999): Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. Int Clin Psychopharmacol 14:19‐28.

George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al (2000): Vagus nerve stimulation: A new tool for brain research and therapy. Biol Psychiatry 47:287‐ 295.

Glass RM (1999): Treating depression as a recurrent or chronic disease. JAMA 281:83‐84.

Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993):

The economic burden of depression in 1990. J Clin Psychi atry 54:405‐418.

Guy W (1976): ECDEUAssessment Manual for Psychopharma cology (Department of Health, Education and Welfare Pub lication No. ADM 76-338). Rockville, MD: U.S. Public Health Service.

Guze SB, Robins E (1970): Suicide and primary affective disorders. Br J Psychiatry 117:437‐438.

Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56‐62.

Hamilton M (1967): Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278‐296.

Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, et al (1998): Vagus nerve stimu lation therapy for partial-onset seizures: A randomized active control trial. Neurologv 51:48‐55.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E.